Amdocs Limited (NASDAQ:DOX) Stock Holdings Increased by Foster & Motley Inc.

Foster & Motley Inc. boosted its stake in shares of Amdocs Limited (NASDAQ:DOXFree Report) by 3.5% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 26,143 shares of the technology company’s stock after purchasing an additional 884 shares during the period. Foster & Motley Inc.’s holdings in Amdocs were worth $2,298,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in DOX. Ronald Blue Trust Inc. increased its stake in shares of Amdocs by 82.3% in the third quarter. Ronald Blue Trust Inc. now owns 1,203 shares of the technology company’s stock worth $102,000 after acquiring an additional 543 shares during the last quarter. PFG Advisors raised its stake in shares of Amdocs by 4.8% during the 3rd quarter. PFG Advisors now owns 3,402 shares of the technology company’s stock worth $287,000 after purchasing an additional 155 shares in the last quarter. Impact Partnership Wealth LLC acquired a new stake in shares of Amdocs during the 3rd quarter valued at about $171,000. DAVENPORT & Co LLC grew its stake in shares of Amdocs by 8.7% in the 3rd quarter. DAVENPORT & Co LLC now owns 2,785 shares of the technology company’s stock valued at $235,000 after buying an additional 223 shares in the last quarter. Finally, GHP Investment Advisors Inc. increased its holdings in Amdocs by 1.4% in the third quarter. GHP Investment Advisors Inc. now owns 81,151 shares of the technology company’s stock worth $6,564,000 after buying an additional 1,130 shares during the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

Analyst Ratings Changes

DOX has been the topic of several analyst reports. Citigroup increased their price target on shares of Amdocs from $96.00 to $104.00 and gave the stock a “buy” rating in a research note on Wednesday, January 17th. Barclays upped their price target on Amdocs from $105.00 to $115.00 and gave the stock an “overweight” rating in a research note on Thursday, February 8th. Finally, lowered Amdocs from a “strong-buy” rating to a “buy” rating in a report on Friday, March 15th. Five research analysts have rated the stock with a buy rating, According to, Amdocs has an average rating of “Buy” and an average price target of $108.60.

Read Our Latest Stock Report on DOX

Amdocs Price Performance

Shares of Amdocs stock opened at $86.38 on Tuesday. Amdocs Limited has a twelve month low of $78.38 and a twelve month high of $99.75. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.29 and a current ratio of 1.29. The firm has a market cap of $10.15 billion, a P/E ratio of 18.48, a price-to-earnings-growth ratio of 1.40 and a beta of 0.69. The firm’s 50-day simple moving average is $89.96 and its 200-day simple moving average is $87.31.

Amdocs (NASDAQ:DOXGet Free Report) last announced its quarterly earnings results on Tuesday, February 6th. The technology company reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.40 by $0.16. The firm had revenue of $1.25 billion for the quarter, compared to analysts’ expectations of $1.24 billion. Amdocs had a return on equity of 17.79% and a net margin of 11.30%. The business’s revenue was up 5.0% compared to the same quarter last year. During the same period in the prior year, the business posted $1.33 earnings per share. As a group, research analysts expect that Amdocs Limited will post 5.87 EPS for the current fiscal year.

Amdocs Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Friday, March 29th will be paid a $0.479 dividend. The ex-dividend date is Wednesday, March 27th. This represents a $1.92 dividend on an annualized basis and a yield of 2.22%. This is a positive change from Amdocs’s previous quarterly dividend of $0.44. Amdocs’s payout ratio is currently 41.11%.

Amdocs Company Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Featured Stories

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with's FREE daily email newsletter.